The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.

Related Articles


New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease

Alberto Lorenzatti, Peter P Toth,


Citation: European Cardiology Review 2020;15:e04.

Impacts of Adipocytokines and Obesity-associated Inflammatory Markers on…

Morihiro Matsuda,

Citation: European Cardiology Review 2020;15:e45.

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence

Koji Hasegawa, Maki Komiyama, Yuko Takahashi,


Citation: European Cardiology Review 2019;14(1):60–1

Obesity and Weight Loss

C Richard Conti,

Citation: European Cardiology Review 2018;13(2):93–4.